Pregnancy of Unknown Location
On this page
Direct answer
A positive pregnancy test with an empty uterus on transvaginal scan defines pregnancy of unknown location (PUL) — neither intrauterine pregnancy nor ectopic pregnancy nor failing pregnancy has been visualised, and the task is to resolve the location safely without missing a tubal gestation. The discriminating tools are serial quantitative beta-human chorionic gonadotropin at 48 hours and serum progesterone: values at or above the discriminatory zone (roughly 1500-2000 IU/L for transvaginal ultrasound) with an empty uterus raise ectopic suspicion; a rise below about 35% over 48 hours suggests a non-viable pregnancy (intrauterine or ectopic), a rise of 35% or more roughly doubles the odds of a viable intrauterine pregnancy and mandates re-scan. The outcome is one of four: a developing intrauterine pregnancy, an ectopic pregnancy, a failing PUL, or a persisting PUL that keeps surveillance going.
What you must remember
- Definition verbatim: positive pregnancy test with no signs of intrauterine or extrauterine pregnancy on transvaginal scan — a transient state, not a diagnosis.
- Discriminatory zone: at a beta-hCG of about 1500-2000 IU/L a healthy intrauterine sac should be visible transvaginally; an empty uterus above this level is ectopic until proven otherwise, though intervening too early (with moderate hCG) misclassifies viable pregnancies — one reason the zone guides, not dictates.
- The 48-hour hCG rule: in a viable intrauterine pregnancy the minimum expected rise is about 35-49% at 48 hours; a rise under 35% or a plateau signals non-viable gestation; a fall suggests failing pregnancy, but a slow fall can still be ectopic — a failing PUL needs follow-up to negativity, not discharge.
- Progesterone triage: serum progesterone at or above about 25-60 nmol/L (varies by unit and guideline) suggests a viable pregnancy; a level under roughly 20 nmol/L (about 6-10 ng/mL) strongly predicts non-viability and low ectopic risk in many protocols.
- Disposition: haemodynamically stable, compliant woman — outpatient serial hCG and repeat scan; abdominal pain, bleeding with risk factors, or an unstable patient — admission and gynaecological review; peritoneal signs mean theatre, not tests.
- Never give anti-D logic-free: rhesus-negative women receiving medical or surgical management for ectopic or failing pregnancy receive anti-D per protocol; expectant management of very early pregnancy loss typically does not require it (follow local guidance).
- Persisting PUL: hCG plateauing without a visible pregnancy after surveillance; a proportion of these are early ectopics — some protocols offer methotrexate or diagnostic laparoscopy rather than endless follow-up.
- Communication duty: the phrase "we cannot see the pregnancy yet" with a clear same-day follow-up plan reduces the panic and the default inappropriate demands for immediate intervention.
A triage pathway in practice
A 29-year-old, six weeks by dates, mild spotting, stable, beta-hCG 900 IU/L, transvaginal scan shows nothing in uterus or adnexa. Plan: repeat beta-hCG at 48 hours alongside progesterone. Outcome one: hCG 2100 with progesterone 40 nmol/L — viable likely, rescan in one week shows an intrauterine sac with yolk sac: resolved as intrauterine. Outcome two: hCG 950, progesterone 12 nmol/L — non-viable trajectory; continue hCG weekly until negative, warning that a plateau or rise during decline reclassifies her as likely ectopic and brings her in. Outcome three: hCG 2200 on the first visit's scan day with an empty uterus — discriminatory zone territory; repeat scan in days (not immediate methotrexate), with explicit ectopic counselling and immediate-return precautions.
The discipline the exam rewards: no single number terminates the pathway — trends plus scans plus clinical state resolve PUL; the price of impatience is either methotrexate into a viable pregnancy or discharge of a tubal rupture in waiting.
How the exam frames it
Numerical single-best-answers dominate: a beta-hCG above the discriminatory zone with an empty uterus points to ectopic; a 48-hour rise under 35% with progesterone under 20 nmol/L points to non-viability; a rise over 35% points to re-scan. The viva layer asks why "hCG above the zone, empty uterus" does not trigger immediate methotrexate — because multiple gestations and late ovulation raise hCG before visibility, so a confirming scan or a clear rising-trend review precedes medical treatment in stable patients. The second viva favourite is the anti-D question and the ectopic-suspicion safety netting: every PUL discharged gets written instructions about pain, syncope and shoulder-tip pain — the words that describe a rupturing tube.
Frequently asked questions
What defines a pregnancy of unknown location?
A positive pregnancy test with no intrauterine or extrauterine pregnancy seen on transvaginal ultrasound — a working state awaiting classification.
What is the discriminatory zone of beta-hCG?
The level (about 1500-2000 IU/L transvaginally) at which a healthy intrauterine pregnancy should be visible; an empty uterus above it heightens ectopic suspicion.
How does a 48-hour hCG trend classify PUL?
A rise of at least 35% favours viable intrauterine pregnancy (re-scan); a smaller rise or plateau suggests a non-viable gestation, intrauterine or ectopic.
What does a low serum progesterone indicate?
A level commonly under about 20 nmol/L predicts a non-viable pregnancy with low ectopic risk, allowing expectant follow-up to hCG negativity.
When is a persisting PUL actively treated?
When hCG plateaus without a visualised pregnancy despite surveillance — options include methotrexate or laparoscopy, since many persisting PULs are early ectopic gestations.